“3D MOLECULAR DOCKING COMBINED WITH AI-DRIVEN VIRTUAL SCREENING TO REPURPOSE FDA-APPROVED DRUGS FOR RARE NEURODEGENERATIVE DISEASES” (2024) International Journal of Experimental Biology, 2(01), pp. 50–73. Available at: https://www.ijeb.online/index.php/IJEB/article/view/23 (Accessed: 20 November 2026).